ArticleBMC cancer2015

The differential anti-tumour effects of zoledronic acid in breast cancer - evidence for a role of the activin signaling pathway.

Caroline Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.